Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1/2 1

Status

Unknown 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3Other hematologic neoplasm 1Lymphoid 1

Conditions

Cardiotoxicity 2Breast Neoplasms 2Women With Breast Cancer 1Heart Failure 1

Interventions

Cyclophosphamide 424Trastuzumab 415Paclitaxel 376Docetaxel 314Capecitabine 266Letrozole 262Carboplatin 257Doxorubicin 213Tamoxifen 184Fulvestrant 176Epirubicin 176Radiotherapy 171Anastrozole 164pembrolizumab 152pertuzumab 147Surveys and Questionnaires 146Exercise 142exemestane 128Vinorelbine 127palbociclib 124Bevacizumab 123Magnetic Resonance Spectroscopy 120Blood Specimen Collection 120Drug Therapy 106Albumin-Bound Paclitaxel 105Gemcitabine 99130-nm albumin-bound paclitaxel 98pyrotinib 92eribulin 90Biopsy 88

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Bisoprolol × Breast × Clear all
NCT04588935 2023-02-08

Prevention of Cardiovascular Diseases Caused by Complex Treatment of Patients With Primary Operated Breast Cancer

State Institution "Republican Scientific and Practical Center" Cardiology, Belarus

Phase 2 Completed
100 enrolled
Breast

Women With Breast Cancer

NCT02236806 2022-02-01

SAFE

Azienda Ospedaliero-Universitaria Careggi

Phase 3 Unknown
262 enrolled
Breast

Breast Neoplasms, Cardiotoxicity

NCT01016886 2016-02-09

MANTICORE

AHS Cancer Control Alberta

Phase 1/2 Unknown
99 enrolled
Breast

Breast Neoplasms, Heart Failure, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡